These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


321 related items for PubMed ID: 23243176

  • 1. Clinical aspects of cytomegalovirus antiviral resistance in solid organ transplant recipients.
    Le Page AK, Jager MM, Iwasenko JM, Scott GM, Alain S, Rawlinson WD.
    Clin Infect Dis; 2013 Apr; 56(7):1018-29. PubMed ID: 23243176
    [Abstract] [Full Text] [Related]

  • 2. Diversity of antiviral-resistant human cytomegalovirus in heart and lung transplant recipients.
    Iwasenko JM, Scott GM, Naing Z, Glanville AR, Rawlinson WD.
    Transpl Infect Dis; 2011 Apr; 13(2):145-53. PubMed ID: 21070537
    [Abstract] [Full Text] [Related]

  • 3. Analysis and characterization of antiviral drug-resistant cytomegalovirus isolates from solid organ transplant recipients.
    Lurain NS, Bhorade SM, Pursell KJ, Avery RK, Yeldandi VV, Isada CM, Robert ES, Kohn DJ, Arens MQ, Garrity ER, Taege AJ, Mullen MG, Todd KM, Bremer JW, Yen-Lieberman B.
    J Infect Dis; 2002 Sep 15; 186(6):760-8. PubMed ID: 12198609
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prophylaxis and treatment of cytomegalovirus disease in recipients of solid organ transplants: current approach and future challenges.
    Puius YA, Snydman DR.
    Curr Opin Infect Dis; 2007 Aug 15; 20(4):419-24. PubMed ID: 17609603
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Preemptive treatment for cytomegalovirus viremia to prevent cytomegalovirus disease in solid organ transplant recipients.
    Strippoli GF, Hodson EM, Jones C, Craig JC.
    Transplantation; 2006 Jan 27; 81(2):139-45. PubMed ID: 16436954
    [Abstract] [Full Text] [Related]

  • 15. Antiviral drugs for cytomegalovirus diseases.
    Biron KK.
    Antiviral Res; 2006 Sep 27; 71(2-3):154-63. PubMed ID: 16765457
    [Abstract] [Full Text] [Related]

  • 16. Antiviral treatment of cytomegalovirus infection.
    Ahmed A.
    Infect Disord Drug Targets; 2011 Oct 27; 11(5):475-503. PubMed ID: 21827432
    [Abstract] [Full Text] [Related]

  • 17. Emergence and persistence of multiple antiviral-resistant CMV strains in a highly immunocompromised child.
    Iwasenko JM, Scott GM, Ziegler JB, Rawlinson WD.
    J Clin Virol; 2007 Oct 27; 40(2):152-5. PubMed ID: 17698411
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cytomegalovirus infection and disease in the new era of immunosuppression following solid organ transplantation.
    Fisher RA.
    Transpl Infect Dis; 2009 Jun 27; 11(3):195-202. PubMed ID: 19228345
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.